Stock DZ
31.03.2018 kl 22:36
4377

x global VP of early clinical development at AstraZeneca working as scientific advisor for PCI biotech.

http://pcibiotech.no/scientific-advisory-committee/

Professor Andrew Hughes

Professor Andrew Hughes is strategy director of the experimental cancer medicine team at The Christie. This role involves overseeing the clinical contribution to Phase 1 cancer clinical trials and a strategic growth of the research by up to 10 fold over the next 5 years. Previous to that he was Global VP of early clinical development at AstraZeneca Pharmaceuticals leading over 50 research and early clinical development programmes of novel candidate drugs
Redigert 31.03.2018 kl 22:38 Arkivert